SETD6 and urinary bladder carcinoma: To confirm the mRNA results, we used immunoblotting to determine SETD6 protein levels and found that SETD6 was minimally detectable in primary urothelial cells, higher in transformed bladder epithelial cells and > 50 fold higher level in bladder cancer cell lines compared with primary cells (Figure 1C and Supplementary Figure 2).